يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Niels WCJ Van De Donk"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    دورية أكاديمية
    689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2

    المؤلفون: Lien Vandenberk, Paula Rodríguez-Otero, Maria-Victoria Mateos, Ajai Chari, Bhagirathbhai Dholaria, Deeksha Vishwamitra, Sheri Skerget, M Damiette Smit, Kalpana Bakshi, Sangmin Lee, Nizar Bahlis, Niels WCJ van de Donk, Raluca Verona

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/2051-1426

    URL الوصول: https://doaj.org/article/dbff19d26aaa4728b508224666963930

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1

    المؤلفون: Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesus Berdeja, Albert Oriol, Niels WCJ Van De Donk, Paula Rodriguez Otero, Elham Askari, Maria-Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Y. Krishnan, Deeksha Vishwamitra, Xuewen Ma, Xiang Qin, Katharine S. Gries, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Christoph Heuck, Jesús San-Miguel, Philippe Moreau

    المصدر: Blood. 140:384-387

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0fa4b97f62b70bc1d70b6581395bf4c3
    https://doi.org/10.1182/blood-2022-159707

    أضف إلى المفضلة
  3. 3
    Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma

    المؤلفون: Philippe Moreau, Niels WCJ van de Donk, Hareth Nahi, Albert Oriol, Ajay K Nooka, Thomas Martin, Laura Rosinol, Lionel Karlin, Lotfi Benboubker, Maria-Victoria Mateos, Rakesh Popat, Joaquín Martínez-López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Yunsi Olyslager, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Rachel Kobos, Saad Z Usmani

    المصدر: Moreau, P, van de Donk, N W, Nahi, H, Oriol, A, Nooka, A K, Martin, T, Rosinol, L, Karlin, L, Benboubker, L, Mateos, M-V, Popat, R, Martínez-López, J, Sidana, S, Delforge, M, Pei, L, Trancucci, D, Olyslager, Y, Uhlar, C, Stephenson, T, Rampelbergh, R V, Banerjee, A, Kobos, R & Usmani, S Z 2023, ' Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma ', Future Oncology, vol. 19, no. 12, pp. 811-818 . https://doi.org/10.2217/fon-2023-0171

    مصطلحات موضوعية: Cancer Research, Oncology, General Medicine

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b574d622969d1bf4268f05a26ecf10
    https://research.vumc.nl/en/publications/c5519aef-fda2-470f-b219-c09a1e6c2b1e

    أضف إلى المفضلة
  4. 4
    Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1

    المؤلفون: Diana Cortes-Selva, Tineke Casneuf, Deeksha Vishwamitra, Sarah Stein, Tatiana Perova, Sheri Skerget, Elena Ramos, Laure van Steenbergen, Dries De Maeyer, Rengasamy Boominathan, Onsay Lau, Cuc Davis, Arnob Banerjee, Tara Stephenson, Clarissa M. Uhlar, Rachel Kobos, Jenna D. Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S. Wu, Philippe Moreau, Saad Usmani, Nizar Jacques Bahlis, Niels WCJ Van De Donk, Raluca Verona

    المصدر: Blood. 140:241-243

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ba6f9fa9936194ac18c6a833803e59cc
    https://doi.org/10.1182/blood-2022-162709

    أضف إلى المفضلة
  5. 5
    Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody: Patient-Reported Outcomes from MonumenTAL-1

    المؤلفون: Cyrille Touzeau, Ajai Chari, Carolina Schinke, Monique C. Minnema, Jesus Berdeja, Albert Oriol, Niels WCJ Van De Donk, Paula Rodriguez Otero, Elham Askari, Maria-Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Y. Krishnan, Deeksha Vishwamitra, Xuewen Ma, Xiang Qin, Katharine S. Gries, Kelly Kato, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Chris Heuck, Philippe Moreau, Jesús San-Miguel

    المصدر: Blood. 140:4447-4449

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a39196f75a37c7b9d539cb3b1881c272
    https://doi.org/10.1182/blood-2022-162555

    أضف إلى المفضلة
  6. 6
    Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Anti-B-Cell Maturation Antigen (BCMA)-Exposed Cohort of the CC-220-MM-001 Trial

    المؤلفون: Sagar Lonial, Al-Ola Abdallah, Faiz Anwer, Ashraf Z. Badros, Manisha Bhutani, Abdullah Khan, Brea Lipe, Albert Oriol, Darrell White, Michael Amatangelo, Kexin Jin, Mark Masin, Vi Nguyen, Alpesh Amin, Paulo Maciag, Niels WCJ Van De Donk

    المصدر: Blood. 140:4398-4400

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::60917a747dbd2b683e5c485c4f641ace
    https://doi.org/10.1182/blood-2022-158180

    أضف إلى المفضلة
  7. 7
    Modakafusp Alfa (TAK-573), a Novel CD38-Targeting Attenuated Interferon-Alpha Immunocytokine, Kills MM Cells Via NK Cell Activation

    المؤلفون: Wassilis S.C. Bruins, Rosa Rentenaar, Sabrina Collins, James F. Sampson, Niels WCJ Van De Donk, Sonja Zweegman, Tuna Mutis

    المصدر: Blood. 140:4236-4237

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5c46be200d422ab0e032c0c24d42b82a
    https://doi.org/10.1182/blood-2022-156387

    أضف إلى المفضلة
  8. 8
    Poster: MM-153 Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial Therapy

    المؤلفون: Mounzer Agha, Niels WCJ Van de Donk, Adam D Cohen, Yael C Cohen, Sébastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M Schecter, Kevin C de Braganca, Helen Varsos, Pankaj Mistry, Tito Roccia, Enrique Zudaire, Christina Corsale, Muhammed Akram, Dong Geng, Tonia Nesheiwat, Lida Pacaud, Pieter Sonneveld, Sonja Zweegman

    المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:S178

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e67b309cbfecbe78cf0d3e682be5f47b
    https://doi.org/10.1016/s2152-2650(22)01096-5

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  9. 9
    A NEW RISK STRATIFICATION STRATEGY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN ANALYSIS ON MATURE DATA FROM EUROPEAN CLINICAL TRIALS WITHIN THE HARMONY BIG DATA PLATFORM

    المؤلفون: Mattia D'agostino, Juan José Lahuerta, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels WCJ van de Donk, Hans Salwender, Joan Bladé, Bronno van der Holt, Gastone Castellani, Giovannino Ciccone, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Jesús María Hernandez Rivas, Jesus San Miguel, Mario Boccadoro, Pieter Sonneveld

    المساهمون: Mattia D'agostino, Juan José Lahuerta, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels WCJ van de Donk, Hans Salwender, Joan Bladé, Bronno van der Holt, Gastone Castellani, Giovannino Ciccone, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Jesús María Hernandez Rivas, Jesus San Miguel, Mario Boccadoro, Pieter Sonneveld

    مصطلحات موضوعية: ECOG, Hazard-ratio, Immunomodulatory drug, LDH, newly diagnosed multiple myeloma, OMOP, overall survival, PFS, proteasome inhibitor, R-ISS

    وصف الملف: ELETTRONICO

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______4094::899128da83a37287d5473711af2c8e1f
    http://hdl.handle.net/11585/807867

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء